British Columbia Investment Management Corp Regeneron Pharmaceuticals, Inc. Transaction History

British Columbia Investment Management Corp

  • $16.4 Billion
  • Q3 2025

A detailed history of British Columbia Investment Management Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 15,256 shares of REGN stock, worth $10.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
15,256
Previous 16,829 9.35%
Holding current value
$10.6 Million
Previous $8.84 Million 2.92%
% of portfolio
0.05%
Previous 0.05%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$534.91 - $598.71 $841,413 - $941,770
-1,573 Reduced 9.35%
15,256 $8.58 Million
Q2 2025

Aug 14, 2025
SELL
$483.07 - $625.6 $1.85 Million - $2.4 Million
-3,840 Reduced 18.58%
16,829 $8.84 Million
Q1 2025

May 14, 2025
SELL
$634.14 - $744.83 $58,340 - $68,524
-92 Reduced 0.44%
20,669 $13.1 Million
Q4 2024

Feb 14, 2025
BUY
$701.85 - $1046.91 $1.88 Million - $2.8 Million
2,678 Added 14.81%
20,761 $14.8 Million
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $2.65 Million - $3.11 Million
-2,591 Reduced 12.53%
18,083 $19 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $6.92 Million - $8.4 Million
7,840 Added 61.09%
20,674 $21.7 Million
Q1 2024

May 14, 2024
BUY
$902.69 - $993.35 $492,868 - $542,369
546 Added 4.44%
12,834 $12.4 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $1.92 Million - $2.18 Million
2,478 Added 25.26%
12,288 $10.8 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $79,631 - $97,102
115 Added 1.19%
9,810 $8.07 Million
Q2 2023

Aug 11, 2023
BUY
$700.03 - $830.35 $98,004 - $116,249
140 Added 1.47%
9,695 $6.97 Million
Q1 2023

May 12, 2023
BUY
$680.49 - $826.97 $31,983 - $38,867
47 Added 0.49%
9,555 $7.85 Million
Q4 2022

Feb 10, 2023
SELL
$705.89 - $766.39 $832,950 - $904,340
-1,180 Reduced 11.04%
9,508 $6.86 Million
Q3 2022

Nov 10, 2022
SELL
$573.97 - $724.32 $970,009 - $1.22 Million
-1,690 Reduced 13.65%
10,688 $7.36 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $2.16 Million - $2.91 Million
-3,943 Reduced 24.16%
12,378 $7.32 Million
Q1 2022

May 12, 2022
SELL
$595.12 - $698.43 $1.28 Million - $1.5 Million
-2,147 Reduced 11.63%
16,321 $11.4 Million
Q4 2021

Feb 11, 2022
SELL
$543.48 - $670.97 $487,501 - $601,860
-897 Reduced 4.63%
18,468 $11.7 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $71,179 - $84,439
-124 Reduced 0.64%
19,365 $11.7 Million
Q2 2021

Aug 09, 2021
BUY
$472.8 - $558.54 $1.08 Million - $1.27 Million
2,280 Added 13.25%
19,489 $10.9 Million
Q1 2021

Apr 30, 2021
SELL
$446.73 - $548.2 $215,770 - $264,780
-483 Reduced 2.73%
17,209 $8.14 Million
Q4 2020

Feb 02, 2021
BUY
$478.3 - $607.98 $94,703 - $120,380
198 Added 1.13%
17,692 $8.55 Million
Q3 2020

Nov 10, 2020
BUY
$544.75 - $658.21 $725,062 - $876,077
1,331 Added 8.23%
17,494 $9.79 Million
Q2 2020

Aug 12, 2020
BUY
$493.32 - $643.92 $3.6 Million - $4.71 Million
7,307 Added 82.51%
16,163 $10.1 Million
Q1 2020

May 13, 2020
SELL
$336.18 - $494.43 $3.44 Million - $5.07 Million
-10,245 Reduced 53.64%
8,856 $4.32 Million
Q4 2019

Feb 12, 2020
BUY
$274.13 - $376.51 $2.19 Million - $3 Million
7,977 Added 71.71%
19,101 $7.17 Million
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $4.15 Million - $4.83 Million
-15,168 Reduced 57.69%
11,124 $3.09 Million
Q2 2019

Aug 12, 2019
SELL
$299.6 - $414.82 $2.49 Million - $3.45 Million
-8,307 Reduced 24.01%
26,292 $8.23 Million
Q1 2019

May 08, 2019
SELL
$372.08 - $439.57 $197,946 - $233,851
-532 Reduced 1.51%
34,599 $14.2 Million
Q4 2018

Feb 13, 2019
BUY
$335.82 - $403.04 $651,490 - $781,897
1,940 Added 5.84%
35,131 $13.1 Million
Q3 2018

Nov 13, 2018
SELL
$351.14 - $408.51 $3.21 Million - $3.73 Million
-9,139 Reduced 21.59%
33,191 $13.4 Million
Q2 2018

Aug 09, 2018
SELL
$284.6 - $344.99 $6.63 Million - $8.04 Million
-23,295 Reduced 35.5%
42,330 $14.6 Million
Q1 2018

May 15, 2018
SELL
$315.82 - $393.78 $74,849 - $93,325
-237 Reduced 0.36%
65,625 $22.6 Million
Q4 2017

Feb 20, 2018
BUY
$358.63 - $469.95 $3.28 Million - $4.3 Million
9,157 Added 16.15%
65,862 $24.8 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $24.5 Million - $28.6 Million
56,705
56,705 $25.4 Million

Others Institutions Holding REGN

# of Institutions
1,466
Shares Held
86.5M
Call Options Held
2.38M
Put Options Held
1.61M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email